News summaryReuters, via Investing.comNov 5, 2026, 12:00 PM
Jones Trading initiates Buy coverage with $8 target
Event Nov. 5: Jones Trading initiated Editas coverage at Buy with an $8 price target. The report cited EDIT-401’s >90% preclinical LDL reduction in non-human primates and identified commercial viability as a headwind; article displayed EDIT at $2.72.